Apomorphine Subcutaneous and Dexmethylphenidate Extended-Release Capsules
Determining the interaction of Apomorphine Subcutaneous and Dexmethylphenidate Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: Apomorphine
Generic Name: dexmethylphenidate
Brand name: Focalin, Focalin XR
Synonyms: Dexmethylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apomorphine Subcutaneous-Dexmethylphenidate Hydrochloride
- Apomorphine Subcutaneous-Dexmethylphenidate Tablets
- Apomorphine Subcutaneous-DexPak
- Apomorphine Subcutaneous-DexPak 10 Day Taperpak
- Apomorphine Subcutaneous-DexPak 13 DayTaperpak
- Apomorphine Subcutaneous-DexPak 6 DayTaperpak
- Dexmethylphenidate Extended-Release Capsules-Apra
- Dexmethylphenidate Extended-Release Capsules-Apraclonidine
- Dexmethylphenidate Extended-Release Capsules-Apraclonidine Hydrochloride
- Dexmethylphenidate Extended-Release Capsules-Apraclonidine ophthalmic
- Dexmethylphenidate Extended-Release Capsules-Apremilast
- Dexmethylphenidate Extended-Release Capsules-Aprepitant